MedGraph - Topaaz TM

AI-Powered Platform for Rapid and Precise Drug Design

AI-automated platform designed to revolutionize drug discovery. With de novo design, multiparameter optimization & advanced virtual screening, it empowers researchers to deliver precise, scalable & efficient solutions for drug discovery

MedGraph-Topaaz NCE

Why Choose MedGraph - Topaaz TM

Accelerating Drug Discovery With Scalable and Agile Solutions

AI-Automated Drug Design

AI-Automated Drug Design

Scalable Architecture

Scalable Architecture

Agile Framework

Agile Framework

Agile Framework

Drug Discovery Support

AI-Powered Innovation

99% accuracy

De novo design powered by generative AI delivers novel molecules with desired pharmacological properties

Cloud-Native Architecture

100% scalable

Cloud and on-premise deployment with secure, infrastructure-agnostic designs ensure adaptability to any research environment

Accelerated Discovery

10x faster

Significantly reduce drug discovery timelines from years to weeks with data-intensive, AI-augmented workflows

End-to-End Solution

Complete pipeline

From target selection to preclinical candidate optimization, Topaaz provides a seamless AI-powered workflow for accelerated R&D

Core Features of MedGraph - Topaaz TM

AI-driven inverse design of molecules with desired pharmacological properties in an automated fashion

De Novo Design

Fragment-Based Modeling: Build novel compounds from scratch using Medvolt’s extensive library of fragments

AI-Accelerated Screening: Rapidly identify high-potential candidates for your therapeutic targets

image

Generative AI

Deep Neural Networks: Use top fragments as seeds to probabilistically generate diverse molecules

Active Compound Libraries: Create a vast library of active compounds in record time

image

AI-Driven Optimization

Reinforcement Learning Models: Optimize compounds for safety, efficacy & other pharmacological properties

Automated Candidate Refinement: Modify and evolve structures to ensure clinical success

image

Virtual Screening

Molecular Docking: Predict drug-target interactions and binding mechanisms

Drug-Likeness Prediction: Assess ADME, physicochemical & toxicity properties for lead selection

image

Applications of MedGraph - Topaaz TM

Comprehensive solutions for modern drug discovery and development

Novel Molecule Design

Create unique, active compounds tailored for therapeutic targets.

Target Identification

Rapidly assess target-drug interactions and optimize lead candidates.

Clinical Success Optimization

Ensure candidates meet critical safety and efficacy parameters to advance clinical trials.

Drug Repurposing

Discover alternative uses for existing compounds using AI and predictive analytics.

Workflow of MedGraph - Topaaz TM

Streamlined Workflows for AI-Driven Drug Discovery

01

Input

Start with a target protein structure or specific pharmacological property requirement

02

De Novo Design

Generate novel molecules using Medvolt's fragment library and generative AI

03

Optimization

Refine molecular structures for safety, efficacy, and drug-likeness using reinforcement learning

04

Screening & Validation

Conduct molecular docking, ADME profiling & FEP calculations to identify top candidates

05

Optimized Molecules

Receive a curated library of optimized, validated molecules ready for preclinical testing

Why MedGraph - Topaaz TM Stands Out

Experience the next generation of drug discovery with our cutting-edge platform

99.9%Accuracy Rate

Cutting-Edge AI Models

Advanced generative AI, deep neural networks & reinforcement learning ensure accuracy & scalability

10xFaster Screening

Thorough Screening

From molecular docking to FEP-based binding energy predictions, every stage of discovery is covered.

85%Time Saved

Rapid Timelines

Transition from initial design to validated candidates in weeks, not years.

Our Advanced Platform

Discover our platform's capabilities with advanced features that drive efficiency & accelerate drug discovery

Slide 1
Slide 2
Slide 3
Slide 4
Slide 5
Slide 6
Slide 7
Slide 8
Slide 9
Slide 10
Slide 11
Slide 12
Slide 13

Contact Us For Demo

Click the button below to get started—fill out the form now!

Why Medvolt

Accelerate Discovery

Medvolt's AI-powered platform cuts pre-clinical discovery time by 3x, reduces costs by 15x and lowers failure risk by 25%. Enhance your R&D efficiency with our in silico tools.

High-Throughput Data

Enrich your research with Medvolt's proprietary, gold-standard, high-throughput proprietary datasets. Our AI and NLP solutions deliver speed, precision and scalability.

Expert Collaboration

Our experienced, tech-driven team collaborates globally with leading pharma and biotech companies, ensuring impactful, scalable solutions.